debate: biosimilar therapies - use as indicated, in place of our current biologics
Published 8 years ago • 739 plays • Length 9:02Download video MP4
Download video MP3
Similar videos
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
14:19
regulatory pathway for biosimilars
-
7:21
biologic drugs and biosimilars
-
4:41
biologics, unbranded biologics, and biosimilars - what is the difference?
-
16:44
the current landscape of biosimilars in ibd
-
1:05:56
what’s next? biosimilars: the future of biosimilar drugs in the u.s.
-
7:28
safety concerns rise over the use of biologic drugs
-
4:52
kiran mazumdar shaw on biosimilars
-
21:21
beyond reference biologics: biosimilars on the horizon
-
16:48
biosimilars in ibd: where do we stand today?
-
57:41
webinar: biologics & biosimilars
-
38:15
biosimilars and biologics
-
53:18
utilization of biosimilars: achieving value-based plan management
-
5:58
the availability of multiple biosimilars for 1 biologic
-
21:14
when and how to use immunomodulators and biologics in ibd
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
0:25
the power of biosimilars: the benefits of fda-approved biologics #shorts
-
13:19
what are biosimilar therapies and why should we care?
-
39:48
optimizing biosimilars for safe and effective management of imids
-
1:25:23
biologics & biosimilars webinar w/ alexandra charlton
-
39:16
professor angela thomas: "regulation of biologics & biosimilars"
-
33:12
biosimilar therapy 101